部份中文醋酸去氨加压素处方资料（仅供参考）
治疗类别名称
第八因子的释放血友病A·血管性血友病
欧文商標名
DESMOPRESSIN Injection 4 Kyowa
一般名
デスモプレシン酢酸塩水和物　Desmopressin Acetate Hydrate
化学名
1-Deamino-8-D-arginine-vasopressin acetate trihydrate
略名
DDAVP
分子式
C46H64N14O12S2・C2H4O2・3H2O＝1183.31
構造式
性状
它是一种白色粉末。
溶解性
水，易溶于甲醇或乙酸（100），和微溶于乙醇（99.5）。
药效药理
这种药物是一种药物使止血由凝血因子已，自体的作用是释放凝血因子VIII和被汇集在“体内”或“内皮细胞”血管性血友病因子等。在由健康人（0.1,0.2,0.4μg/ kg）的，因子VIII凝血活性和血管性血友病因子活性的剂量反应试验中以剂量依赖性的方式增加，它已达到在30分钟内的最大峰在给药后1小时。
另外，在A型血友病患者的增加和血管性血友病因子VIII凝血活性增加的血管性血友病因子活性这种药物的类似施用和健康个体后达到在30分钟时的最大峰至1小时。该示例的反应性下降到每次施用这种药物的结果在血友病A和血管性血友病患者的检查三次重复施用和每24小时的反应，在第二轮的例子后的反应是丢失它已被确定
适应症
轻中度血友病A（凝血因子VIII凝血活性是大于或等于2％的患者）
血管性血友病TypeI·TypeIIA
剂量和给药方法
1. 通常情况下，A型血友病是0.2〜0.4μg/ kg的作为去氨加压素醋酸水合物，血管性血友病氏病稀释到0.4μg/ kg的在盐水中约20毫升，和静脉内施用缓慢10至20分钟到。
2. 当术前给予药物，它是静脉内给药于相同的方式在外科手术前130分钟，可以预期。
包装格
10管
生产厂商
协和发酵麒麟有限公司[联合]瑞士辉凌
注：使用以原处方为准：http://www.info.pmda.go.jp/go/pack/2419400A1024_1_12/ 
DESMOPRESSIN Injection 4 Kyowa（デスモプレシン注4協和）
Brand name : DESMOPRESSIN Injection 4 Kyowa
　Active ingredient: Desmopressin acetate hydrate
　Dosage form: injection
　Print on wrapping: 
Effects of this medicine
This medicine acts on blood-coagulation factor to stop bleeding.
It is usually used to control bleeding in connection with spontaneous, injury, dental extraction or surgical procedures in patients with mild/moderate haemophilia A (factor VIII coagulation activity 2% or higher) and Type I/II A von Willebrand's disease.
Before using this medicine, be sure to tell your doctor and pharmacist
If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have hypertension, arteriosclerosis, coronary thrombosis, angina, pregnancy toxemia, chronic kidney disease or anterior pituitary dysfunction.
If you are pregnant or breastfeeding.
If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>>
In general, inject intravenously at a slow speed.
For pre-operative use, inject intravenously at a slow speed 30 minutes before planned surgical procedure.
Precautions while taking this medicine
Be aware of the amount of water ingestion to avoid excessive intake.
Possible adverse reactions to this medicine
The most commonly reported adverse reactions include hot flush, heat sensation, flushing of the face, headache or conjunctival congestion. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
general malaise, headache, nausea [serious water intoxication accompanied by brain edema, coma or convulsion]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
Kyowa Hakko Kirin Co.,Ltd Injection
Published: 8/2013
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.